Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of the international CorEvitas Adolescent Alopecia Areata (AA) Registry, addressing a critical unmet need ...

A phase 3 study demonstrated that ritlecitinib was effective and well tolerated in patients with alopecia areata and ≥ 25% ...

Panelists discuss how the data from the BRAVE-AA1 and BRAVE-AA2 phase 3 trials demonstrated the safety and efficacy of baricitinib, leading to its FDA approval in 2022 as the first systemic treatment ...

This study will evaluate HCW9302 in patients with moderate to severe alopecia areataMIRAMAR, Fla., Feb. 03, 2025 (GLOBE ...

The short answer is yes. Stress is considered an "initiating event" that contributes to hair loss. Learn how hair loss from ...

Dallas Cowboys Cheerleader Armani Latimer brought awareness to alopecia on "My Cause, My Cleats" night. ARLINGTON, Texas — It's an annual celebration for the NFL: “My Cause, My Cleats.” The night is ...

HCW Biologics gets US FDA nod to begin first-in-human phase 1 trial of HCW9302 to treat patients with moderate-to-severe alopecia areata: Miramar, Florida Wednesday, February 5, 2 ...

HCW Biologics shares are trading higher on Monday after the company announced clearance from the Food and Drug Administration ...

A holistic or integrative approach to hair loss considers the hair growth cycle and hair loss from a nutritional, ...

MIRAMAR, Fla. - HCW Biologics Inc. (NASDAQ: HCWB), a clinical-stage biopharmaceutical company with a market capitalization of approximately $12.4 million, announced today that it has received U.S.

Look at your hair loss pattern — alopecia areata causes patchy hair loss ... no matter the cause. Hair loss treatments like finasteride (a daily pill) and topical minoxidil (treatment used ...